Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis

被引:117
|
作者
Mescam-Mancini, Lenaig [1 ]
Allenbach, Yves [2 ,3 ]
Hervier, Baptiste [2 ,4 ]
Devilliers, Herve [5 ]
Mariampillay, Kuberaka [2 ]
Dubourg, Odile [6 ]
Maisonobe, Thierry [6 ]
Gherardi, Romain [7 ]
Mezin, Paulette [1 ]
Preusse, Corinna [3 ]
Stenzel, Werner [3 ]
Benveniste, Olivier [2 ]
机构
[1] CHU Grenoble, Dept Pathol, Inst Pathol, F-38043 Grenoble, France
[2] Univ Paris 06, Dept Med Interne & Immunol Clin, Ctr Reference Malad Neuromusculaires Paris Est, Hop La Pitie Salpetriere,AP HP,DHU I2B,INSERM UMR, Paris, France
[3] Charite, Dept Neuropathol, D-13353 Berlin, Germany
[4] UPMC, INSERM CIMI Paris, INSERM UMRS 1135, Paris, France
[5] Hop Dijon, Dept Med Interne, Dijon, France
[6] Hop La Pitie Salpetriere, AP HP, Ctr Reference Malad Neuromusculaires Paris Est, Lab Neuropathol, Paris, France
[7] Univ Paris Est Creteil Val de Marne UPEC, INSERM, U955, Inst Mondor Rech Biomed,IFR10, F-94010 Creteil, France
关键词
anti-synthetase; idiopathic inflammatory myopathies; dermatomyositis; polymyositis; necrotizing myopathies; IDIOPATHIC INFLAMMATORY MYOPATHY; ANTISYNTHETASE SYNDROME; AUTOANTIBODIES; IMMUNE; DERMATOMYOSITIS; MUSCLE; CLASSIFICATION; POLYMYOSITIS; FEATURES;
D O I
10.1093/brain/awv192
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Idiopathic inflammatory myopathies can be classified as polymyositis, dermatomyositis, immune-mediated necrotizing myopathy, sporadic inclusion body myositis or non-specific myositis. Anti-Jo-1 antibody-positive patients are assigned to either polymyositis or dermatomyositis suggesting overlapping pathological features. We aimed to determine if anti-Jo-1 antibody-positive myopathy has a specific morphological phenotype. In a series of 53 muscle biopsies of anti-Jo-1 antibody-positive patients, relevant descriptive criteria defining a characteristic morphological pattern were identified. They were tested in a second series of anti-Jo-1 antibody-positive patients and compared to 63 biopsies from patients suffering from other idiopathic inflammatory myopathies. In anti-Jo-1 antibody-positive patients, necrotic fibres, which strongly clustered in perifascicular regions, were frequently observed. Sarcolemmal complement deposition was detected specifically in perifascicular areas. Inflammation was mainly located in the perimysium and around vessels in 90.6%. Perimysial fragmentation was observed in 90% of cases. Major histocompatibility complex class I staining was diffusely positive, with a perifascicular reinforcement. Multivariate analysis showed that criteria defining perifascicular pathology: perifascicular necrosis, atrophy, and perimysial fragmentation allow the distinction of anti-Jo-1 antibody-positive patients, among patients suffering from other idiopathic inflammatory myopathies. Anti-Jo-1 antibody-positive patients displayed perifascicular necrosis, whereas dermatomyositis patients exhibited perifascicular atrophy.
引用
收藏
页码:2485 / 2492
页数:8
相关论文
共 50 条
  • [21] Serum biomarkers of interstitial lung disease in jo-1 antibody-positive myositis
    Eggebeen, A.
    Rosas, I.
    Kaminski, N.
    Richards, T.
    Oddis, C.
    Ascherman, D.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4259 - 4259
  • [22] Symptoms spectrum and prognosis in patients with the idiopathic inflammatory myopathy with sera positive for anti-Jo-1 antibody in comparison with patients without presence of the myositis associated autoantibodies
    Mielnik, P
    Wiesik-Szewczyk, E
    Chwalinska-Sadowska, H
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 240 - 240
  • [23] Presence of the anti-Jo-1 autoantibody excludes inclusion body myositis
    Hengstman, GJD
    van Engelen, BGM
    Badrising, UA
    van den Hoogen, FHJ
    van Venrooij, WJ
    ANNALS OF NEUROLOGY, 1998, 44 (03) : 423 - 423
  • [24] Successful therapy of anti-Jo-1 antibody positive polymyositis with leflunomide and a current overview
    Piegsa, M
    Strunk, J
    Lange, U
    Müller-Ladner, U
    AKTUELLE RHEUMATOLOGIE, 2005, 30 (04) : 238 - 244
  • [25] Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis
    VazquezAbad, D
    Rothfield, NF
    ARTHRITIS AND RHEUMATISM, 1996, 39 (02): : 292 - 296
  • [26] Effective treatment of anti Jo-1 antibody-positive polymyositis with cyclosporin
    Tellus, MM
    Buchanan, RRC
    BRITISH JOURNAL OF RHEUMATOLOGY, 1995, 34 (12): : 1187 - 1188
  • [27] Effective treatment of anti Jo-1 antibody-positive polymyositis with cyclosporin
    Dawson, JK
    Abernethy, VE
    Lynch, MP
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (01): : 144 - 145
  • [28] DERMATOMYOSITIS AND PULMONARY FIBROSIS ASSOCIATED WITH ANTI-JO-1 ANTIBODY
    PHILLIPS, TJ
    LEIGH, IM
    WRIGHT, J
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1987, 17 (02) : 381 - 382
  • [29] Destructive Arthropathy Associated with Dermatomyositis Sine Myositis Positive for Anti-Jo-1 and Anti-Cyclic Citrullinated Peptide Antibodies
    Nagashima, Takao
    Sato, Hidetomo
    Minota, Seiji
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (09) : 2133 - 2134
  • [30] ADULT-RESPIRATORY-DISTRESS-SYNDROME IN POLYMYOSITIS PATIENTS WITH THE ANTI-JO-1 ANTIBODY
    CLAWSON, K
    ODDIS, CV
    ARTHRITIS AND RHEUMATISM, 1995, 38 (10): : 1519 - 1523